2022
DOI: 10.36290/vnl.2022.100
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory markers in clinical practice

Abstract: Zápal je všeobecná obranná reakcia tela proti rôznym škodlivým podráždeniam. Diagnostika zápalového procesu a monitorovanie jeho liečby je založené na kombinácii klinických a laboratórnych nálezov. Biochemické zápalové markery slúžia obvykle na podporu diagnózy infekcie, na jej monitorovanie a sledovanie efektívnosti antiinfekčnej liečby. Zápalový marker je potrebné vyberať podľa klinického stavu s ohľadom na zradnosť a nedostatky markerov, so znalosťou ich dynamiky a s ohľadom na dĺžku anamnézy. Ako optimálny… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Metabolic abnormalities are significantly higher in BD compared to the general population and have been linked to unfavorable illness trajectories 15 . Specifically, laboratory markers indicate elevated serum triglycerides and glycosylated hemoglobin, hyperinsulinemia, insulin resistance, and lowered HDL, compared with healthy controls 84 . These increased blood markers of metabolic syndrome have been associated with decreased treatment efficacy and worsened disease course in BD 85 .…”
Section: Bd As An Illness Of Metabolic Let Lagmentioning
confidence: 99%
See 1 more Smart Citation
“…Metabolic abnormalities are significantly higher in BD compared to the general population and have been linked to unfavorable illness trajectories 15 . Specifically, laboratory markers indicate elevated serum triglycerides and glycosylated hemoglobin, hyperinsulinemia, insulin resistance, and lowered HDL, compared with healthy controls 84 . These increased blood markers of metabolic syndrome have been associated with decreased treatment efficacy and worsened disease course in BD 85 .…”
Section: Bd As An Illness Of Metabolic Let Lagmentioning
confidence: 99%
“…15 Specifically, laboratory markers indicate elevated serum triglycerides and glycosylated hemoglobin, hyperinsulinemia, insulin resistance, and lowered HDL, compared with healthy controls. 84 These increased blood markers of metabolic syndrome have been associated with decreased treatment efficacy and worsened disease course in BD. 85 Individuals with BD also demonstrate a greater prevalence of obesity when compared with the general population.…”
Section: Bd As An Illness Of Metabolic Let Lagmentioning
confidence: 99%